Menu
/REGISTER
Montecito
Pac Premier
Citizens
QQQ
Loading...
You are here:  Home  >  Banking & Finance  -  Page 202

Montecito Bank & Trust

Santa Barbara Web Design
Latest

Amgen to lay off 226 in Thousand Oaks

By   /  Wednesday, October 19th, 2011  /  Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen to lay off 226 in Thousand Oaks

Read More →
Latest

Ryland calls the movers: Homebuilder plants headquarters in Westlake Village

By   /  Friday, October 14th, 2011  /  Banking & Finance, Features, Real Estate, Tri-County Public Companies  /  Comments Off on Ryland calls the movers: Homebuilder plants headquarters in Westlake Village

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Santa Barbara software fishes for high-frequency trades

By   /  Friday, October 14th, 2011  /  Banking & Finance, Personal Finance, Top Stories  /  Comments Off on Santa Barbara software fishes for high-frequency trades

Read More →
Latest

Power-One docks outlook on Eurozone austerity

By   /  Tuesday, October 11th, 2011  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Power-One docks outlook on Eurozone austerity

Read More →
Latest

Dole buys blueberry business

By   /  Tuesday, October 11th, 2011  /  Banking & Finance, Latest news, Tri-County Public Companies  /  Comments Off on Dole buys blueberry business

Read More →
Latest

Vitesse slashes work force, faces lawsuit

By   /  Friday, October 7th, 2011  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Vitesse slashes work force, faces lawsuit

Read More →
Latest

Amgen braces for biosimilars rules

By   /  Friday, October 7th, 2011  /  Banking & Finance, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen braces for biosimilars rules

Read More →